en · de · es · fr · pt
sr9009-notes.peptides6155.com › Data › Analytical Detection And Stability — Quick Reference

Analytical Detection And Stability — Quick Reference

By Editorial Desk · published 2025-12-13 · last reviewed 2026-01-25 · Data

Everything below concerns certificate of analysis. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.

Last reviewed on 2026-01-25. Where a claim depends on a specific study, the study is described rather than over-claimed.

Analytical Detection and Stability

Analytical identification of SR9009 typically relies on liquid chromatography coupled with tandem mass spectrometry. In biological samples, researchers first separate the compound from matrix components using protein precipitation, liquid-liquid extraction, or solid-phase extraction. High-performance liquid chromatography with ultraviolet detection and nuclear magnetic resonance spectroscopy can support structural confirmation of reference materials. Because SR9009 is a small, relatively lipophilic molecule, reverse-phase columns and acidic mobile phases are common. Laboratories often include isotope-labeled internal standards to improve quantification and to correct for ion suppression.

Stability depends on physical form, temperature, light exposure, and solvent. Solid SR9009 is generally stored cold and dry, with protection from light to limit degradation. Dimethyl sulfoxide stocks are common for laboratory work, but repeated freeze-thaw cycles can reduce compound integrity. Aqueous solutions may be less stable than organic stocks, and the ethyl ester in the structure can be susceptible to hydrolysis under certain conditions. Researchers typically validate storage conditions and recheck purity before quantitative experiments, especially when using archived material.

Regulatory treatment of SR9009 varies by country and region. It is not approved as a pharmaceutical, and several jurisdictions restrict its sale for human consumption. Some authorities classify it as a research chemical, a prescription-only substance, or a prohibited performance-enhancing agent in sport. Purchasers may encounter certificates of analysis, but these documents do not guarantee identity, purity, or legality. In research settings, institutional safety reviews and controlled procurement help ensure that materials are handled under appropriate oversight. The absence of harmonized rules means that legal status can change and requires verification.

Mechanism and Preclinical Findings

Preclinical reports have linked SR9009 to improved endurance and altered energy expenditure in rodents. Such findings have prompted interest in whether REV-ERB activation can influence skeletal muscle metabolism. However, the reported effects depend on dose, route, and experimental model, and replication across laboratories is limited. Human trials have not established comparable outcomes, so claims about exercise performance remain speculative. The absence of controlled human data is a central limitation in interpreting these observations.

The mechanism of action involves binding to REV-ERB receptors and recruiting corepressor complexes, which represses target gene transcription. This contrasts with many nuclear receptor agonists that activate transcription. Downstream effects may include changes in autophagy, mitochondrial biogenesis, and lipid handling, but the precise pathways remain an active area of study. Whether these molecular events translate into meaningful physiological effects in humans is unresolved. Most evidence comes from cultured cells and rodent models rather than human participants.

Sr9009 at a glance

PropertyValueNotes
Common synonymsSR9009; StenabolicNickname is not a chemical name.
Typical analytical methodLC-MS/MSOften with isotope-labeled internal standard.
Storage temperature-20 °CDesiccated and protected from light.
Solution stabilityDMSO stock; avoid freeze-thawStore at -20 to -80 °C.
Regulatory statusNot approved; varies by countryMay be restricted as research chemical.

SR9009 Background and Mechanism

SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms and metabolic gene expression. In laboratory experiments, SR9009 binds these receptors and alters transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. It is not a naturally occurring compound and has no approved therapeutic use. Research interest stems from its ability to modify energy metabolism in cells and animal models.

In rodent studies, SR9009 has been reported to increase mitochondrial content in skeletal muscle and improve exercise endurance under some conditions. These findings led to popular descriptions such as an exercise mimetic, although that term oversimplifies the biology. Effects vary by dose, timing, tissue, and model. The compound's influence on circadian pathways means that time of administration can matter in experiments. Whether similar metabolic changes occur in humans remains largely unexplored in controlled published trials.

Pharmacokinetic data for SR9009 are limited in published literature. Some reports indicate low oral bioavailability and rapid clearance in animals, which complicates interpretation of exposure and effect. Researchers often use injected routes in preclinical work to achieve measurable systemic levels. Analytical studies rely on mass spectrometry to detect the parent compound and its metabolites. Questions about tissue distribution, active metabolites, and long-term consequences remain open. Species differences in metabolism can affect observed half-life and target engagement.

Related pages on this site

SR9009 Background and Receptor Mechanism

SR9009 binds REV-ERB receptors and alters their repressive activity on target genes. This action can change transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. In rodent studies, treated animals have shown changes in muscle oxidative capacity and exercise performance, though effects vary by dose, duration, and model. The precise molecular steps connecting receptor binding to whole-body outcomes are still an active area of investigation. Findings in animals do not automatically translate to humans.

Because REV-ERB receptors are core clock components, SR9009 has been examined for effects on daily rhythms as well as metabolism. Research has explored whether the compound can shift or reinforce circadian gene expression in tissues such as liver and muscle. Some studies report improved metabolic markers in obese or diabetic mice, while others show context-dependent responses. Questions remain about which effects are direct, which are secondary to timing, and how they might differ across species.

SR9009 is a synthetic small molecule studied as an agonist of REV-ERB nuclear receptors. REV-ERB alpha and REV-ERB beta help regulate circadian rhythms and metabolic gene expression. In laboratory research, SR9009 has been used to probe how these receptors affect skeletal muscle, liver, and adipose tissue. The compound was identified in academic drug-discovery work and is often described in scientific literature by its chemical name and research code. It is not an approved medicine, and human clinical data remain limited or absent.

Analytical Detection and Regulatory Status

Scientific discussion of SR9009 often separates animal evidence from human anecdote. Rodent studies provide controlled data on endurance, metabolism, and gene expression, but they use specific strains, doses, and treatment durations. Human reports are mostly uncontrolled and cannot establish cause and effect. Open questions include oral bioavailability, tissue distribution, metabolic stability, and long-term effects. Review articles generally call for more rigorous pharmacokinetic and safety research before any clinical use could be considered.

Analytical methods for SR9009 typically rely on liquid chromatography coupled with tandem mass spectrometry. The technique can separate the parent compound from related substances and detect low concentrations in biological matrices. Urine and blood are common samples in anti-doping testing, while in vitro studies may use cell culture media. Rapid metabolism and low expected concentrations make method validation important for reliable identification. Exact metabolite patterns can vary by species and are not fully mapped.

Regulatory treatment of SR9009 reflects its investigational status. The compound has no approved human therapeutic indication, and sports authorities prohibit its use. It appears on anti-doping lists as a non-approved substance or metabolic modulator, depending on the list version. Products sold online as research chemicals are not quality-controlled medicines, so their identity and purity can differ from the label. Such products may also contain unlisted compounds, which complicates both testing and safety assessment.

Supporting material

The State Council said inspectors would target edible oil trade fairs and wholesale markets and called for inspections of oil being used at restaurants, school cafeterias, work canteens and kitchens at construction sites. The State Council also stated that businesses that use recycled oil would be forced to close temporarily or lose their business license while peddlers who sell the oil could be criminally prosecuted. In October 2013, a man from eastern China's Jiangsu Province was sentenced to life imprisonment for profiting heavily from making and selling gutter oil. In January 2014, Zhu Chuanfeng was sentenced to death with a two-year reprieve, and his brothers Zhu Chuanqing and Zhu Chuanbo were sentenced to life in prison for selling gutter oil.

action potential The local change in voltage that occurs when the membrane potential of a specific location along the membrane of a cell rapidly depolarizes, such as when a nerve impulse is transmitted between neurons.

Knoxville's first major annexation following the Civil War came in 1869, when it annexed the city of East Knoxville, an area east of First Creek that had incorporated in 1856. In 1883, Knoxville annexed Mechanicsville, which had developed just northwest of the city as a village for Knoxville Iron Company and other factory workers. In the 1870s and 1880s, the development of Knoxville's streetcar system (electrified by William Gibbs McAdoo in 1890) led to the rapid development of suburbs on the city's periphery. Neighborhoods such as Fort Sanders, Fourth and Gill, Old North Knoxville, Happy Holler, and Parkridge, are all rooted in "streetcar suburbs" developed during this period. In 1888, the area now consisting of Fort Sanders and the UT campus were incorporated as the City of West Knoxville, and in 1889, the area now consisting of Old North Knoxville and Fourth and Gill incorporated as the City of North Knoxville. Knoxville annexed both in 1897. In 1907, Parkridge, Chilhowee Park, and adjacent neighborhoods incorporated as Park City. Lonsdale, a factory village northwest of the city, and Mountain View, located south of Park City, incorporated that same year. Oakwood, which developed alongside the Southern Railway's Coster rail yard, was incorporated in 1913. In 1917, Knoxville annexed these four cities, along with the burgeoning suburb of Sequoyah Hills and parts of South Knoxville, effectively more than doubling the city's population, and increasing its land area from 4 to 26 square miles (10 to 67 km2).

Keratinocytes are the primary type of cell found in the epidermis, the outermost layer of the skin. In humans, they constitute 90% of epidermal skin cells. Basal cells in the basal layer (stratum basale) of the skin are sometimes referred to as basal keratinocytes. Keratinocytes form a barrier against environmental damage by heat, UV radiation, water loss, pathogenic bacteria, fungi, parasites, and viruses. A number of structural proteins, enzymes, lipids, and antimicrobial peptides contribute to maintain the important barrier function of the skin. Keratinocytes differentiate from epidermal stem cells in the lower part of the epidermis and migrate towards the surface, finally becoming corneocytes and eventually being shed, which happens every 40 to 56 days in humans.

Sources: en.wikipedia.org

Supporting material

In a move seen as marking her return to political life, former prime minister Liz Truss writes an article for The Sunday Telegraph in which she says her economic agenda was never given a "realistic chance". 6 February 2022–2023 National Health Service strikes: Ambulance staff and nurses walk out, with further disruption to follow in the week, in what is expected to be the biggest-ever round of NHS strikes. Foreign Secretary James Cleverly offers his condolences to victims of the 7.8 magnitude Turkey–Syria earthquake and says the UK is deploying emergency response teams, including 76 search and rescue specialists, equipment and rescue dogs. The government issues an urgent warning to British travellers and holidaymakers who may be in or planning to visit the region. 7 February Former Met Police officer David Carrick, one of the UK's most prolific sex offenders, is sentenced at Southwark Crown Court to 36 life sentences with a minimum term of 30 years in prison. Sunak performs a cabinet reshuffle. Greg Hands is named as the new Conservative Party chairman; Grant Shapps becomes the secretary of state for energy, security and net zero in a newly-formed department; Kemi Badenoch is appointed as the first secretary of state at the newly created Department for Business and Trade, with continued responsibility as equalities minister. 8 February Ukraine's President Volodymyr Zelensky addresses a joint session of Parliament during his first visit to the UK since Russia invaded his country. He later visits Buckingham Palace for a meeting with the King.

History of environmental chemistry – history of the scientific study of the chemical and biochemical phenomena that occur in natural places. History of immunochemistry – history of the branch of chemistry that involves the study of the reactions and components of the immune system. History of medicinal chemistry – history of the discipline at the intersection of chemistry, especially synthetic organic chemistry, and pharmacology and various other biological specialties, where they are involved with design, chemical synthesis and development for market of pharmaceutical agents (drugs). History of natural product chemistry – history of the scientific study of chemical compounds or substances produced by living organisms—history of chemical compounds found in nature that usually have a pharmacological or biological activity for use in pharmaceutical drug discovery and drug design. History of neurochemistry – history of the specific study of neurochemicals, which include neurotransmitters and other molecules such as neuro-active drugs that influence neuron function. History of computational chemistry – history of the branch of chemistry that uses principles of computer science to assist in solving chemical problems. History of chemo-informatics – history of the use of computer and informational techniques, applied to a range of problems in the field of chemistry. History of molecular mechanics – history of the uses of Newtonian mechanics to model molecular systems. History of flavor chemistry – history of the use of chemistry to engineer artificial and natural flavors.

Senator Bernie Sanders official US Senate website Campaign website Appearances on C-SPAN Biography at the Biographical Directory of the United States Congress Financial information (federal office) at the Federal Election Commission Legislation sponsored at the Library of Congress Profile at Vote Smart

Sources: en.wikipedia.org

Frequently asked questions

How is SR9009 measured in samples?

The most common approach is liquid chromatography-tandem mass spectrometry, often after extraction from blood, urine, or tissue. Ultraviolet detection and nuclear magnetic resonance spectroscopy are used mainly for reference material characterization. Isotope-labeled internal standards improve accuracy.

What storage conditions are typical for SR9009?

Solid material is usually kept at -20 °C, desiccated, and protected from light. Dimethyl sulfoxide stocks should be stored cold and subjected to minimal freeze-thaw cycles. Aqueous solutions are generally less stable and should be prepared fresh when possible.

Is SR9009 legal to buy?

Legality depends on the country and the intended use. It is not an approved medicine, and some places restrict or ban sales for human consumption. Buyers should verify local rules and product documentation before procurement.

What is SR9009?

It is a synthetic compound that acts as an agonist at REV-ERBα and REV-ERBβ. It is used mainly as a research chemical to study circadian and metabolic pathways. It is not approved for human therapeutic use.

Network